Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 13-14/2021

23.02.2021 | original article

Complete hemogram: simple and cost-effective in staging and predicting outcome in acute pancreatitis

verfasst von: Dr. Parmeshwar Ramesh Junare, Dr. Prasanta Debnath, Dr. Sujit Nair, Dr. Sanjay Chandnani, Dr. Suhas Udgirkar, Dr. Ravi Thange, Dr. Shubham Jain, Dr. Rahul Deshmukh, Dr. Partha Debnath, Dr. Pravin Rathi, Dr. Qais Contractor, Dr. Akshay Deshpande

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2021

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

An important goal in management of acute pancreatitis (AP) is early prediction and recognition of disease severity. Various predictive scoring systems are in clinical use with their own limitations and there is always a quest for simple, practical, quantifiable, dynamic and readily available markers for predicting disease severity and outcome. Complete hemogram is routinely ordered in all patients with AP. In recent years red cell distribution width (RDW), neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR) and platelet lymphocyte ratio (PLR) have been found to be independent predictors of prognosis in various benign and malignant conditions. This prospective study evaluated complete hemogram based markers in AP.

Material and methods

Complete hemogram analysis was done and NLR, LMR, PLR values were calculated. Development of organ failure, the need for intensive care unit (ICU) admission and interventions, development of complications (local/systemic) and 100-day mortality were assessed.

Results

In this study 160 subjects of AP were included. Complete hemogram analysis was performed within 24 h after admission. C‑reactive protein, RDW, NLR, PLR and bedside index of severity in acute pancreatitis (BISAP) values were higher in severe AP than moderate AP group than mild AP group, while LMR values were decreased in the corresponding severe, moderate and mild AP groups (p < 0.001). The NLR performed best for prediction of ICU admission, organ failure, interventions and mortality with area under receiver operating curve (AUROC) were 0.943, 0.940, 0.902 and 0.910, respectively.

Conclusion

Hemogram based markers are simple, objective, dynamic and readily available. They can be considered in addition to conventional multifactorial scoring systems for prediction of outcome and prognosis of AP.
Literatur
2.
Zurück zum Zitat Pandol SJ, Saluja AK, Imrie CW, Banks PA. Acute pancreatitis: bench to the bedside. Gastroenterology. 2007;132:1127–51. PubMedCrossRef Pandol SJ, Saluja AK, Imrie CW, Banks PA. Acute pancreatitis: bench to the bedside. Gastroenterology. 2007;132:1127–51. PubMedCrossRef
3.
Zurück zum Zitat Bollen TL, van Santvoort HC, Besselink MG, et al. The Atlanta classification of acute pancreatitis revisited. Br J Surg. 2008;95:6–21. PubMedCrossRef Bollen TL, van Santvoort HC, Besselink MG, et al. The Atlanta classification of acute pancreatitis revisited. Br J Surg. 2008;95:6–21. PubMedCrossRef
4.
Zurück zum Zitat Bradley EL 3rd. A clinically based classification system for acute pancreatitis. In: summary of the international symposium on acute pancreatitis, Atlanta, GA, 11–13 September 1992. Arch Surg. 1993;128:586–90. PubMedCrossRef Bradley EL 3rd. A clinically based classification system for acute pancreatitis. In: summary of the international symposium on acute pancreatitis, Atlanta, GA, 11–13 September 1992. Arch Surg. 1993;128:586–90. PubMedCrossRef
5.
Zurück zum Zitat Bülbüller N, Doğru O, Ayten R, Akbulut H, İlhan YS, Çetinkaya Z. Procalcitonin is a predictive marker for severe acute pancreatitis. Ulus Travma Acil Cerrahi Derg. 2006;12:115–20. PubMed Bülbüller N, Doğru O, Ayten R, Akbulut H, İlhan YS, Çetinkaya Z. Procalcitonin is a predictive marker for severe acute pancreatitis. Ulus Travma Acil Cerrahi Derg. 2006;12:115–20. PubMed
6.
Zurück zum Zitat Balthazar EJ, Freeny PC, van Sonnenberg E. Imaging and intervention in acute pancreatitis. Radiology. 1994;193:297–306. PubMedCrossRef Balthazar EJ, Freeny PC, van Sonnenberg E. Imaging and intervention in acute pancreatitis. Radiology. 1994;193:297–306. PubMedCrossRef
7.
Zurück zum Zitat Hunziker S, Celi LA, Lee J, et al. Red cell distribution width improves the simplified acute physiology score for risk prediction in unselected critically ill patients. Crit Care. 2012;16:R89. PubMedPubMedCentralCrossRef Hunziker S, Celi LA, Lee J, et al. Red cell distribution width improves the simplified acute physiology score for risk prediction in unselected critically ill patients. Crit Care. 2012;16:R89. PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Teng JJ, Zhang J, Zhang TY, et al. Prognostic value of peripheral blood lymphocyte-to monocyte ratio in patients with solid tumors: a meta-analysis. Onco Targets Ther. 2016;9:37–47. PubMed Teng JJ, Zhang J, Zhang TY, et al. Prognostic value of peripheral blood lymphocyte-to monocyte ratio in patients with solid tumors: a meta-analysis. Onco Targets Ther. 2016;9:37–47. PubMed
9.
Zurück zum Zitat Chen L, Lou Y, Chen Y, et al. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. Int J Clin Pract. 2014;68:1034–40. PubMedCrossRef Chen L, Lou Y, Chen Y, et al. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. Int J Clin Pract. 2014;68:1034–40. PubMedCrossRef
10.
Zurück zum Zitat Smith RA, Bosonnet L, Raraty M, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466–72. PubMedCrossRef Smith RA, Bosonnet L, Raraty M, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466–72. PubMedCrossRef
11.
Zurück zum Zitat Kinoshita A, Onoda H, Imai N, et al. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer. 2012;107:988–93. PubMedPubMedCentralCrossRef Kinoshita A, Onoda H, Imai N, et al. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer. 2012;107:988–93. PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Proctor MJ, Morrison DS, Talwar D, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow inflammation outcome study. Br J Cancer. 2011;104:726–34. PubMedPubMedCentralCrossRef Proctor MJ, Morrison DS, Talwar D, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow inflammation outcome study. Br J Cancer. 2011;104:726–34. PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47:2633–41. PubMedCrossRef Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011;47:2633–41. PubMedCrossRef
14.
Zurück zum Zitat Akıllı NB, Yortanlı M, Mutlu H, et al. Prognostic importance of neutrophil-lymphocyte ratio in critically ill patients: short-and long-term outcomes. Am J Emerg Med. 2014;32:1476–80. PubMedCrossRef Akıllı NB, Yortanlı M, Mutlu H, et al. Prognostic importance of neutrophil-lymphocyte ratio in critically ill patients: short-and long-term outcomes. Am J Emerg Med. 2014;32:1476–80. PubMedCrossRef
15.
Zurück zum Zitat Uhl W, Warshaw A, Imrie C, et al. IAP Guidelines for the surgical management of acute pancreatitis. Pancreatology. 2002;2:565–73. PubMedCrossRef Uhl W, Warshaw A, Imrie C, et al. IAP Guidelines for the surgical management of acute pancreatitis. Pancreatology. 2002;2:565–73. PubMedCrossRef
16.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29. PubMedCrossRef Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29. PubMedCrossRef
17.
Zurück zum Zitat Singh VK, Wu BU, Bollen TL, et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009;104:966–71. PubMedCrossRef Singh VK, Wu BU, Bollen TL, et al. A prospective evaluation of the bedside index for severity in acute pancreatitis score in assessing mortality and intermediate markers of severity in acute pancreatitis. Am J Gastroenterol. 2009;104:966–71. PubMedCrossRef
18.
Zurück zum Zitat Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg. 2006;93(6):738–44. PubMedCrossRef Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg. 2006;93(6):738–44. PubMedCrossRef
19.
Zurück zum Zitat Mortele KJ, Wiesner W, Intriere L, Shankar S, Zou KH, Kalantari BN, et al. A modified CT severity index for evaluating acute pancreatitis:improved correlation with patient outcome. AJR Am J Roentgenol. 2004;183(5):1261–5. PubMedCrossRef Mortele KJ, Wiesner W, Intriere L, Shankar S, Zou KH, Kalantari BN, et al. A modified CT severity index for evaluating acute pancreatitis:improved correlation with patient outcome. AJR Am J Roentgenol. 2004;183(5):1261–5. PubMedCrossRef
20.
Zurück zum Zitat Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638–52. PubMedCrossRef Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638–52. PubMedCrossRef
21.
Zurück zum Zitat Felderbauer P, Muller C, Bulut K, et al. Pathophysiology and treatment of acute pancreatitis: new therapeutic targets‑a ray of hope. Basic Clin Pharmacol Toxicol. 2005;97:342–50. PubMedCrossRef Felderbauer P, Muller C, Bulut K, et al. Pathophysiology and treatment of acute pancreatitis: new therapeutic targets‑a ray of hope. Basic Clin Pharmacol Toxicol. 2005;97:342–50. PubMedCrossRef
22.
Zurück zum Zitat Yang SQ, Xu JG. Effect of glutamine on serum interleukin‑8 and tumor necrosis factor-alpha levels in patients with severe pancreatitis. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:129–31. PubMed Yang SQ, Xu JG. Effect of glutamine on serum interleukin‑8 and tumor necrosis factor-alpha levels in patients with severe pancreatitis. Nan Fang Yi Ke Da Xue Xue Bao. 2008;28:129–31. PubMed
23.
Zurück zum Zitat Xu YH, Chen K, Cui SL, Wang H. Advances in the study of pro-inflammatory and anti-inflammatory factors in the pathogenesis of acute pancreatitis. Shi Jie Hua Ren Xiao Hua Za Zhi. 2010;18:1912–8. Xu YH, Chen K, Cui SL, Wang H. Advances in the study of pro-inflammatory and anti-inflammatory factors in the pathogenesis of acute pancreatitis. Shi Jie Hua Ren Xiao Hua Za Zhi. 2010;18:1912–8.
24.
Zurück zum Zitat Yubero S, Ramudo L, Manso MA, et al. Mechanismsof dexamethasone-mediated chemokine down-regulation inmild and severe acute pancreatitis. Biochim Biophys Acta. 2009;12:1205–11. CrossRef Yubero S, Ramudo L, Manso MA, et al. Mechanismsof dexamethasone-mediated chemokine down-regulation inmild and severe acute pancreatitis. Biochim Biophys Acta. 2009;12:1205–11. CrossRef
25.
Zurück zum Zitat Pinhu L, Qin Y, Xiong B, You Y, Li J, Sooranna SR. Overexpressionof Fas and FasL is associated with infectious complications andseverity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes. Inflammation. 2014;37:1202–12. PubMedCrossRef Pinhu L, Qin Y, Xiong B, You Y, Li J, Sooranna SR. Overexpressionof Fas and FasL is associated with infectious complications andseverity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes. Inflammation. 2014;37:1202–12. PubMedCrossRef
26.
Zurück zum Zitat England J, Down M. Red-cell-volume distribution curves and the measurement of anisocytosis. Lancet. 1974;1:701–3. PubMedCrossRef England J, Down M. Red-cell-volume distribution curves and the measurement of anisocytosis. Lancet. 1974;1:701–3. PubMedCrossRef
27.
Zurück zum Zitat Fukuta H, Ohte N, Mukai S, Saeki T, Asada K, Wakami K, et al. Elevated plasma levels of B‑type natriuretic peptide but not C‑reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J. 2009;50:301–12. PubMedCrossRef Fukuta H, Ohte N, Mukai S, Saeki T, Asada K, Wakami K, et al. Elevated plasma levels of B‑type natriuretic peptide but not C‑reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J. 2009;50:301–12. PubMedCrossRef
28.
Zurück zum Zitat Kahramanca Ş, Özgehan G, Şeker D, et al. Neutrophil-to-lymphocyte ratio as a predictor of acute appendicitis. Ulus Travma Acil Cerrahi Derg. 2014;20:19–22. PubMedCrossRef Kahramanca Ş, Özgehan G, Şeker D, et al. Neutrophil-to-lymphocyte ratio as a predictor of acute appendicitis. Ulus Travma Acil Cerrahi Derg. 2014;20:19–22. PubMedCrossRef
29.
Zurück zum Zitat Lee SK, Lee SC, Park JW, Kim SJ. The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study. BMC Surg. 2014;14:100. PubMedPubMedCentralCrossRef Lee SK, Lee SC, Park JW, Kim SJ. The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study. BMC Surg. 2014;14:100. PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Chen L, Lou Y, Chen Y, Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. Int J Clin Pract. 2014;68(8):1034–40. PubMedCrossRef Chen L, Lou Y, Chen Y, Yang J. Prognostic value of the neutrophil-to-lymphocyte ratio in patients with acute-on-chronic liver failure. Int J Clin Pract. 2014;68(8):1034–40. PubMedCrossRef
31.
Zurück zum Zitat Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993–6. PubMedCrossRef Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97:993–6. PubMedCrossRef
32.
Zurück zum Zitat Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–4. PubMedCrossRef Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–4. PubMedCrossRef
33.
Zurück zum Zitat Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008;32:1757–62. PubMedCrossRef Gomez D, Farid S, Malik HZ, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008;32:1757–62. PubMedCrossRef
34.
Zurück zum Zitat Azab B, Jaglall N, Atallah JP, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology. 2011;11:445–52. PubMedCrossRef Azab B, Jaglall N, Atallah JP, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology. 2011;11:445–52. PubMedCrossRef
35.
Zurück zum Zitat Suppiah A, Malde D, Arab T, et al. The prognostic value of the neutrophil- lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg. 2013;17:675–81. PubMedCrossRef Suppiah A, Malde D, Arab T, et al. The prognostic value of the neutrophil- lymphocyte ratio (NLR) in acute pancreatitis: identification of an optimal NLR. J Gastrointest Surg. 2013;17:675–81. PubMedCrossRef
36.
Zurück zum Zitat Jeon TJ, Park JY. Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis. World J Gastroenterol. 2017;23(21):3883–9. PubMedPubMedCentralCrossRef Jeon TJ, Park JY. Clinical significance of the neutrophil-lymphocyte ratio as an early predictive marker for adverse outcomes in patients with acute pancreatitis. World J Gastroenterol. 2017;23(21):3883–9. PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Kokulu K, Günaydın YK, Akıllı NB, Köylü R, Sert ET, Köylü Ö, et al. Relationship between the neutrophil-to-lymphocyte ratio in acute pancreatitis and the severity and systemic complications of the disease. Turk J Gastroenterol. 2018;29(6):684–91. PubMedPubMedCentralCrossRef Kokulu K, Günaydın YK, Akıllı NB, Köylü R, Sert ET, Köylü Ö, et al. Relationship between the neutrophil-to-lymphocyte ratio in acute pancreatitis and the severity and systemic complications of the disease. Turk J Gastroenterol. 2018;29(6):684–91. PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Pinhu L, Qin Y, Xiong B, You Y, Li J, Sooranna SR. Overexpression of Fas and FasL is associated with infectious complications and severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes. Inflammation. 2014;37(4):1202–12. PubMedCrossRef Pinhu L, Qin Y, Xiong B, You Y, Li J, Sooranna SR. Overexpression of Fas and FasL is associated with infectious complications and severity of experimental severe acute pancreatitis by promoting apoptosis of lymphocytes. Inflammation. 2014;37(4):1202–12. PubMedCrossRef
40.
Zurück zum Zitat de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. PubMedPubMedCentralCrossRef de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):R192. PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197(4):466–72. PubMedCrossRef Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197(4):466–72. PubMedCrossRef
42.
Zurück zum Zitat Zampieri FG, Ranzani OT, Sabatoski V, de Souza HP, Barbeiro H, da Neto LM, et al. An increase in mean platelet volume after admission is associated with higher mortality in critically ill patients. Ann Intensive Care. 2014;4:20. PubMedPubMedCentralCrossRef Zampieri FG, Ranzani OT, Sabatoski V, de Souza HP, Barbeiro H, da Neto LM, et al. An increase in mean platelet volume after admission is associated with higher mortality in critically ill patients. Ann Intensive Care. 2014;4:20. PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Kaplan M, Ates I, Oztas E, Yuksel M, Akpinar MY, Coskun O, et al. A new marker to determine prognosis of acute pancreatitis: PLR and NLR combination. J Med Biochem. 2018;37(1):21–30. PubMedPubMedCentralCrossRef Kaplan M, Ates I, Oztas E, Yuksel M, Akpinar MY, Coskun O, et al. A new marker to determine prognosis of acute pancreatitis: PLR and NLR combination. J Med Biochem. 2018;37(1):21–30. PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86–105. PubMedCrossRef Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86–105. PubMedCrossRef
45.
46.
Zurück zum Zitat Senol K, Saylam B, Kocaay F, Tez M. Red-cell distribution width as a predictor of mortality in acute pancreatitis. Am J Emerg Med. 2013;31:687–9. PubMedCrossRef Senol K, Saylam B, Kocaay F, Tez M. Red-cell distribution width as a predictor of mortality in acute pancreatitis. Am J Emerg Med. 2013;31:687–9. PubMedCrossRef
47.
Zurück zum Zitat Ganji A, Esmaeilzadeh A, Ghanaei O, Saberi A, Taherzadeh D, Sazgarnia S, et al. Predictive value of red blood cell distribution width for mortality in patients with acute pancreatitis: a systematic review and meta-analysis. Med J Islam Repub Iran. 2017;31:124. PubMedPubMedCentralCrossRef Ganji A, Esmaeilzadeh A, Ghanaei O, Saberi A, Taherzadeh D, Sazgarnia S, et al. Predictive value of red blood cell distribution width for mortality in patients with acute pancreatitis: a systematic review and meta-analysis. Med J Islam Repub Iran. 2017;31:124. PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Azab B, Camacho-Rivera M, Taioli E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. Plos One. 2014;9(11):e112361. PubMedPubMedCentralCrossRef Azab B, Camacho-Rivera M, Taioli E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. Plos One. 2014;9(11):e112361. PubMedPubMedCentralCrossRef
Metadaten
Titel
Complete hemogram: simple and cost-effective in staging and predicting outcome in acute pancreatitis
verfasst von
Dr. Parmeshwar Ramesh Junare
Dr. Prasanta Debnath
Dr. Sujit Nair
Dr. Sanjay Chandnani
Dr. Suhas Udgirkar
Dr. Ravi Thange
Dr. Shubham Jain
Dr. Rahul Deshmukh
Dr. Partha Debnath
Dr. Pravin Rathi
Dr. Qais Contractor
Dr. Akshay Deshpande
Publikationsdatum
23.02.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 13-14/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01821-2

Weitere Artikel der Ausgabe 13-14/2021

Wiener klinische Wochenschrift 13-14/2021 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungstipps